Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Accounts payable | $ (996) | $ (24,573) | $ 22,856 |
| Accrued expenses and other current liabilities | (7,104) | 2,671 | 8,316 |
| Deferred revenue | 12,307 | (418) | (8,799) |
| Proceeds from exercise of stock options | 909 | 4,203 | 16,998 |
| Proceeds from PIPE | 0 | 0 | 250,000 |
| Related Party | |||
| Accounts payable | 623 | (9,381) | 8,145 |
| Accrued expenses and other current liabilities | (1,986) | 2,966 | (1,293) |
| Deferred revenue | 9,246 | 2,572 | (20,959) |
| Proceeds from PIPE | $ 0 | $ 0 | $ 25,000 |